Who are the key players in North America Cell Therapy Technologies Market industry?

The top 5 key players in the North America Cell Therapy Technologies Market include Thermo Fisher Scientific, Lonza Group, Merck KGaA, Becton Dickinson (BD), and GE Healthcare. These companies provide advanced cell processing, expansion, preservation, and analytical solutions to support research, clinical trials, and commercialization of cell therapies.

Which segment accounted for the largest North America Cell Therapy Technologies Market share?

In 2023, the research applications segment held the largest share of the North America Cell Therapy Technologies Market. Growing academic and industry-funded research in oncology and regenerative medicine, coupled with technological advancements in cell processing, have contributed towards this segment’s dominance.

What are the factors driving the North America Cell Therapy Technologies Market?

Key drivers include increased R&D funding, governmental support for advanced therapeutics, and surging clinical adoption of cell therapies for cancer and rare diseases. For instance, Lonza's expansion of its manufacturing facility supports the growing demand for clinical-grade cell therapies in the region.

Which type accounted for the largest North America Cell Therapy Technologies Market share?

The consumables segment accounted for the largest share in the North America Cell Therapy Technologies Market. High consumable usage in cell culture, expansion, and preservation, as well as the recurring purchase rate, fuels segment growth and makes it a critical component of the cell therapy technology ecosystem.

Home Healthcare

North America Cell Therapy Technologies Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2035)

Q: What is the North America Cell Therapy Technologies Market growth?

The North America Cell Therapy Technologies Market is experiencing significant growth, driven by increased investments in regenerative medicine. For example, Thermo Fisher Scientific's acquisition of Brammer Bio has accelerated manufacturing capacities, supporting a rising demand for cell-based therapies and technology innovations across the region.

North America Cell Therapy Technologies Market: by Type (Stem Cell Therapy, Non-Stem Cell Therapy), Application (Oncology, Cardiovascular Disease, Orthopedics, Wound Healing, Autoimmune Disease, Others), Distribution Channels (Direct Tender, Retail Sales, Online Sales, Distributors, Hospital Pharmacy, Others), Technology (T-Cell Therapy, CAR-T Therapy, NK Cell Therapy, Dendritic Cell Therapy, Stem Cell Processing, Cell Expansion), Organization Size (Small, Medium, Large) and By North America Historical & Forecast Period (2020-2035) Comprehensive Study 2025

Last Updated: 31-07-2025 | Format: PDF | Report ID:20259

Market Segmentation

Metrics	Details
Years	2020-2035
Base Year	2025
Market Size	5800
Regions	United States, Canada, Mexico
Segments	By Type: Stem Cell Therapy, Non-Stem Cell Therapy, Allogeneic Cell Therapy, Autologous Cell Therapy, Somatic Cell Therapy, Gene Modified Cell Therapy; By Application: Oncology, Cardiovascular Diseases, Orthopedics, Wound Healing, Autoimmune Diseases, Others
Players	Thermo Fisher Scientific, Becton Dickinson, Merck KGaA, Lonza Group, Sartorius AG, GE Healthcare, Danaher Corporation, Miltenyi Biotec, Terumo BCT, MaxCyte Inc., STEMCELL Technologies, Thermogenesis Holdings, Bio-Techne Corporation, Bluebird Bio, Fate Therapeutics

Frequently asked questions

Key Questions Answered

»What is the market size and growth rate of the global and regional market by various segments?
»What is the market size and growth rate of the market for selective countries?
»Which region or sub-segment is expected to drive the market in the forecast period?
»What factors are estimated to drive and restrain the market growth?
»What are the key technological and market trends shaping the market?
»What are the key opportunities in the market?
»What are the key companies operating in the market?
»Which company accounted for the highest market share?

Why Choose Bussiness Insights?

»Strong Industry Focus
»Extensive Product Offerings
»Customer Research Services
»Robust Research Methodology
»Comprehensive Reports
»Latest Technological Developments
»Value Chain Analysis
»Potential Market Opportunities
»Growth Dynamics
»Quality Assurance
»Post-sales Support
»Regular Report Updates

Study period:

2020-2035

Base year:

2026

Historical data

2020-2024

NO OF PAGE:

167

Customize This Report to Suit Your Requirements

Name

Bussiness Email

country

Phone number

Consulting Service

How Will You Befit From our consulting service

Get in touch with Us

US +91 89837 31618 (Tool Free)

sales [at] bussinessinsights.com

Market Segmentation

Metrics	Details
Years	2020-2035
Base Year	2025
Market Size	5800
Regions	United States, Canada, Mexico
Segments	By Type: Stem Cell Therapy, Non-Stem Cell Therapy, Allogeneic Cell Therapy, Autologous Cell Therapy, Somatic Cell Therapy, Gene Modified Cell Therapy; By Application: Oncology, Cardiovascular Diseases, Orthopedics, Wound Healing, Autoimmune Diseases, Others
Players	Thermo Fisher Scientific, Becton Dickinson, Merck KGaA, Lonza Group, Sartorius AG, GE Healthcare, Danaher Corporation, Miltenyi Biotec, Terumo BCT, MaxCyte Inc., STEMCELL Technologies, Thermogenesis Holdings, Bio-Techne Corporation, Bluebird Bio, Fate Therapeutics